It is a consumer goods private limited company based in Kolkata, West Bengal, India, established in 2005.
2005 | Kolkata, West Bengal, India | AmalgamatedFortune Pharmaceuticals Private Limited, a amalgamated private limited company, was established on 28 July 2005 in Kolkata, West Bengal, India. Engaging in health & beauty retail & distribution within the trade sector, it holds CIN: U51397WB2005PTC104428. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.81 M.
It upholds a compliant status. Its leadership includes Himanshu Mishra Kumar (Director), Sandeep Kumar (Director). Past directors included Puspjeet Kumar, Amit Sultania. It holds no open charges and ₹9.00 M settled loans. Its latest AGM occurred on 28 December 2020, with the balance sheet filed on 31 March 2020. It is based at Omer Mansion 3Rd Floor Room No C1 29A Weston Street Bow Bazar, Kolkata, West Bengal, 700012.
U51397WB2005PTC104428
104428
28 July 2005
₹1.00 M
₹0.81 M
Roc Kolkata
Unlisted
Amalgamated
Explore comprehensive insights into Fortune Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Himanshu Mishra Kumar | Director | 30 Apr 2008 | Current |
| Sandeep Kumar | Director | 28 Jul 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Apr 2008 | Past |
| Pramod Abcsdd | Director | 22 Jul 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Fortune Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 70.17% decrease. The company also saw a substantial improvement in profitability, with a 203.16% increase in profit. The company's net worth moved up by a moderate rise of 5.08%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Fortune Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹9,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Feb 2012 | Icici Bank Limited | ₹3.00 M | Satisfied |
| 18 May 2009 | 3I Infotech Trusteeship Services Limited | ₹6.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Fortune Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Fortune Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fortune Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Fortune Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Dec 2020 as per latest MCA records. was completed.
Fortune Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Kolkata. was recorded as a recent event.
The activity A charge registered on 20 Feb 2012 via Charge ID 10340480 with Icici Bank Limited was fully satisfied on 21 Mar 2017. was completed.
The activity A charge with Icici Bank Limited of Rs. 3.00 M registered on 20 Feb 2012 with Charge ID 10340480 was modified on 09 Jan 2013. was completed.
Progress on A charge registered on 18 May 2009 via Charge ID 10162661 with 3I Infotech Trusteeship Services Limited was fully satisfied on 02 Mar 2012. was documented.
A charge with Icici Bank Limited amounted to Rs. 3.00 M with Charge ID 10340480 was registered on 20 Feb 2012. was recorded as a recent event.
The CIN of Fortune Pharmaceuticals Private Limited is U51397WB2005PTC104428.
Fortune Pharmaceuticals Private Limited is headquartered at Omer Mansion 3Rd Floor Room No C1 29A Weston Street Bow Bazar, Kolkata, West Bengal, 700012.
Fortune Pharmaceuticals Private Limited was incorporated on 28 July 2005.
The current directors of Fortune Pharmaceuticals Private Limited are
The primary industry of Fortune Pharmaceuticals Private Limited is Trade.
Fortune Pharmaceuticals Private Limited is unlisted.
The authorized capital of Fortune Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.81 M.
The compliance status of Fortune Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX